Manchester Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Manchester Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-150	Closed	-$2K	–	818
2020 Q4	$2K	Hold	150	–	–	﹤0.01%	625
2020 Q3	$2K	Hold	150	–	–	﹤0.01%	481
2020 Q2	$2K	Hold	150	–	–	﹤0.01%	533
2020 Q1	$2K	Hold	150	–	–	﹤0.01%	523
2019 Q4	$4K	Hold	150	–	–	﹤0.01%	496
2019 Q3	$3K	Hold	150	–	–	﹤0.01%	498
2019 Q2	$4K	Hold	150	–	–	﹤0.01%	529
2019 Q1	$7K	Hold	150	–	–	﹤0.01%	591
2018 Q4	$10K	Hold	150	–	–	﹤0.01%	470
2018 Q3	$9K	Hold	150	–	–	﹤0.01%	480
2018 Q2	$10K	Hold	150	–	–	﹤0.01%	484
2018 Q1	$8K	Hold	150	–	–	﹤0.01%	480
2017 Q4	$9K	Hold	150	–	–	﹤0.01%	445
2017 Q3	$7K	Hold	150	–	–	﹤0.01%	442
2017 Q2	$8K	Hold	150	–	–	﹤0.01%	440
2017 Q1	$7K	Hold	150	–	–	﹤0.01%	456
2016 Q4	$6K	Hold	150	–	–	﹤0.01%	460
2016 Q3	$6K	Hold	150	–	–	﹤0.01%	472
2016 Q2	$3K	Hold	150	–	–	﹤0.01%	510
2016 Q1	$2K	Hold	150	–	–	﹤0.01%	581
2015 Q4	$4K	Hold	150	–	–	﹤0.01%	634
2015 Q3	$3K	Buy	+150	New	+$2.72K	﹤0.01%	616

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Manchester Capital Management's AERI Position: Q1 2021 in Review

Manchester Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 150 shares — an estimated $2K sold.

Manchester Capital Management first reported a position in AERI in Q3 2015 and held it in 22 quarters. The position peaked at $10K in Q4 2018. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.

Manchester Capital Management reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Manchester Capital Management sold 150 Aerie Pharmaceuticals shares in Q1 2021, an estimated $2K.
Manchester Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 22 quarters.
Manchester Capital Management's Aerie Pharmaceuticals position peaked at $10K in Q4 2018.
158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.